Prestige Consumer Healthcare Inc. PBH

46.61 0.96 2.10% as of 25 Sep
Market cap
$2.2B
P/E
13.0×
Growth Flags show if company had growth for consecutive years

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Mar '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20 Mar '19 Mar '18 Mar '17
Revenue
1,088.71 1,137.76 1,125.36 1,127.73 1,086.81 943.37 963.01 975.78 1,041.18 882.06
Revenue Growth
(4.31%) 1.10% (0.21%) 3.76% 15.21% (2.04%) (1.31%) (6.28%) 18.04% 9.40%
Cost of Revenue
493.13 503.30 500.91 502.43 466.17 395.89 410.79 420.20 464.67 381.77
Gross Profit
595.58 634.46 624.45 625.29 620.65 547.47 552.22 555.58 576.50 500.29
SG&A Expenses
265.23 263.93 259.47 252.42 264.80 223.70 236.31 232.85 232.68 217.47
Operating Income
309.41 336.78 342.43 (22.41) 329.92 297.40 291.16 67.50 215.47 205.64
Non-operating Income/Expense
(51.91) (52.59) (66.40) (71.50) (67.46) (93.29) (100.00) (105.56) (108.39) (94.79)
Non-operating Interest Expenses
42.34 47.63 67.16 69.16 64.29 82.33 96.22 105.08 106.27 93.55
EBT
257.50 284.19 276.03 (93.91) 262.46 204.11 191.15 (38.05) 107.09 110.85
Income Tax Provision
67.20 69.58 66.69 (11.61) 57.08 39.43 48.87 (2.25) (232.48) 41.46
Income after Tax
190.30 214.61 209.34 (82.31) 205.38 164.68 142.28 (35.80) 339.57 69.40
Dividends (Preferred)
— — 0.00 — 0.00 — — — — —
Net Income Common
190.30 214.61 209.34 (82.31) 205.38 164.68 142.28 (35.80) 339.57 69.40
EPS (Basic)
3.93 4.32 4.21 (1.65) 4.09 3.28 2.81 (0.69) 6.40 1.31
EPS (Diluted)
3.91 4.29 4.17 (1.65) 4.04 3.25 2.78 (0.69) 6.34 1.30
Shares (Basic, Weighted)
48.46 49.70 49.76 49.89 50.26 50.21 50.72 52.07 53.10 52.98
Shares (Diluted, Weighted)
48.72 50.08 50.18 49.89 50.84 50.61 51.14 52.07 53.53 53.36
Gross Margin
54.71% 55.76% 55.49% 55.45% 57.11% 58.03% 57.34% 56.94% 55.37% 56.72%
EBIT Margin
28.42% 29.60% 30.43% (1.99%) 30.36% 31.53% 30.23% 6.92% 20.70% 23.31%
EBT margin
23.65% 24.98% 24.53% (8.33%) 24.15% 21.64% 19.85% (3.90%) 10.29% 12.57%
Net Profit Margin
17.48% 18.86% 18.60% (7.30%) 18.90% 17.46% 14.77% (3.67%) 32.61% 7.87%
Free Cash Flow Margin
22.64% 21.38% 21.27% 19.68% 23.03% 22.62% 21.03% 18.32% 18.98% 16.53%
EBITDA
342.48 368.70 378.34 14.57 366.24 332.55 323.96 105.21 255.64 240.07
EBIT
309.41 336.78 342.43 (22.41) 329.92 297.40 291.16 67.50 215.47 205.64
Income from Continuous Operations
190.30 214.61 209.34 (82.31) 205.38 164.68 142.28 (35.80) 339.57 69.40
Consolidated Net Income/Loss
190.30 214.61 209.34 (82.31) 205.38 164.68 142.28 (35.80) 339.57 69.40
EPS (Basic, from Continuous Ops)
3.93 4.32 4.21 (1.65) 4.09 3.28 2.81 (0.69) 6.40 1.31
EPS (Basic, Consolidated)
3.93 4.32 4.21 (1.65) 4.09 3.28 2.81 (0.69) 6.40 1.31
EPS (Diluted, from Cont. Ops)
3.91 4.29 4.17 (1.65) 4.04 3.25 2.78 (0.69) 6.34 1.30
Shares (Diluted, Average)
48.72 50.08 50.18 49.89 50.84 50.61 51.14 52.07 53.53 53.36
EPS (Diluted, Consolidated)
3.91 4.29 4.17 (1.65) 4.04 3.25 2.78 (0.69) 6.34 1.30
EBITDA Margin
31.46% 32.41% 33.62% 1.29% 33.70% 35.25% 33.64% 10.78% 24.55% 27.22%
Operating Cash Flow Margin
23.66% 22.11% 22.12% 20.37% 23.92% 24.98% 22.55% 19.40% 20.18% 16.86%

Fold the line items

In millions of $ except per-share values · columns are period end dates